IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 350 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $267 | -72.4% | 5,273 | -79.4% | 0.03% | -71.1% |
Q4 2022 | $966 | -99.9% | 25,580 | +39.7% | 0.10% | +26.0% |
Q2 2022 | $678,000 | +100.0% | 18,310 | +64.5% | 0.08% | +102.6% |
Q4 2021 | $339,000 | -12.2% | 11,134 | -3.2% | 0.04% | -17.4% |
Q3 2021 | $386,000 | +56.9% | 11,500 | +122.3% | 0.05% | +15.0% |
Q3 2020 | $246,000 | -50.1% | 5,174 | -53.8% | 0.04% | -45.2% |
Q1 2018 | $493,000 | +77.3% | 11,190 | +102.0% | 0.07% | +49.0% |
Q4 2017 | $278,000 | -2.5% | 5,540 | -1.1% | 0.05% | +6.5% |
Q3 2017 | $285,000 | -25.2% | 5,600 | -25.3% | 0.05% | -36.1% |
Q2 2017 | $381,000 | – | 7,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |